Back to Journals » OncoTargets and Therapy » Volume 11

Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine

Total article views   Abstract views HTML views PDF downloads Totals
2,036 Dovepress* 1,778 134+ 372 1,912
PubMed Central* 0 124 56 124
Totals 1,778 258 428 2,036
*Since 19 April 2018
+Since July 2016

View citations on PubMed Central and Google Scholar